資源描述：
《血府逐瘀湯聯(lián)合前列地爾注射液治療冠心病心絞痛的臨床研究》由會員上傳分享，免費(fèi)在線閱讀，更多相關(guān)內(nèi)容在學(xué)術(shù)論文-天天文庫。
1、血府逐瘀湯聯(lián)合前列地爾注射液治療冠心病心絞痛的臨床研究 摘要：目的運(yùn)用中西醫(yī)醫(yī)學(xué)理論全面認(rèn)識冠心病心絞痛，初步探討中西醫(yī)結(jié)合治療冠心病心絞痛的臨床經(jīng)驗(yàn)，并通過臨床病例觀察研究對血府逐瘀湯聯(lián)合前列地爾注射液治療冠心病心絞痛的臨床效果進(jìn)行初步評定，為應(yīng)用中西醫(yī)結(jié)合治療冠心病心絞痛提供新思路、新療法、新治療方案。方法隨機(jī)將80例冠心病心絞痛患者分為治療組40例和對照組40例。治療組給予血府逐瘀湯1劑/d，2次/d，水煎服，每次200ml，同時聯(lián)合前列地爾100～200μg，靜脈推注，1次/d。對照組給予消心痛，口服，10mg/次，3次/d。結(jié)果治療組各項(xiàng)指標(biāo)均優(yōu)于對照
2、組，P<0.05。結(jié)論臨床驗(yàn)證血府逐瘀湯聯(lián)合前列地爾注射液可有效改善冠心病心絞痛的臨床癥狀，可減少硝酸甘油使用量并改善心電圖情況，本法值得推廣?！ ￡P(guān)鍵詞：血府逐瘀湯；前列地爾；冠心病心絞痛 ClinicalStudyonTreatmentofAnginaPectorisofCoronaryHeartDiseasewithXuefuzhuyuDecoctionCombinedwithAlprostadilInjection MEIXiao-quan1，CHENChang-qing2，CHENXiao-bing1，HEShan-ying1，HEYong-lian
3、g1，HEYi-guang1，SUNXiao-yong3 ?。?.DepartmentofInternalMedicine，AnyuanWomenandChildrenHospital，Ganzhou342100，Jiangxi，China； 2.DepartmentofInternalMedicine，XinfengHospitalofTraditionalChineseMedicine，Ganzhou341600，Jiangxi，China； 3.DepartmentofTraditionalChineseMedicine，F(xiàn)irstAffiliatedH
4、ospitalofGannanMedicalCollege，Ganzhou341000Jiangxi，China） Abstract：ObjectiveTousethewesternmedicinetheoryofcomprehensiveunderstandingofcoronaryheartdiseaseanginapectoris，preliminarystudyofintegratedTraditionalChineseandWesternMedicineclinicalexperienceinthetreatmentofanginapectorisof
5、coronaryheartdisease，clinicaleffectandthroughtheclinicalobservationofXuefuzhuyuDecoctionCombinedwithAlprostadilInjectioninthetreatmentofanginapectorisofpreliminaryevaluation，fortheapplicationofcombinationoftraditionalChineseandWesternmedicinetoprovidenewideasandtreatmentofcoronaryhear
6、tdiseaseanginapectoristhenewtherapy，newtreatment.Methods80patientswithanginapectoriswererandomlydividedintothetreatmentgroupof40casesand40casesinthecontrolgroup.ThetreatmentgroupwasgivenXuefuzhuyuDecoctionof1dosesof/d，2times/d，waterdecoction，200mleachtime，atthesametimecombinedwithalpr
7、ostadil100～200μg，intravenousinjection，the1/d.Thecontrolgroupreceivedisosorbidedinitrate，oral，10mg/，3/d.ResultsTheindexesofthetreatmentgroupwerebetterthanthecontrolgroup，P<0.05.ConclusionTheclinicalvalidationofXuefuzhuyuDecoctionCombinedwithAlprostadilInjectioncaneffectivelychangethecl
8、inica
